Article
16 Oct 2025
FDA Approves Celltrion's Aflibercept Biosimilar
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
15 Sep 2025
Sandoz And Regeneron Settle Aflibercept BPCIA Case
Article
14 Aug 2025
Final Judgment Of Non-Infringement Entered In Alnylam V. Pfizer Vaccine Patent Dispute
Article
30 May 2025
FDA Approves Bio-Thera And Hikma's Ustekinumab Biosimilar
Article
07 May 2025
District Of New Jersey Denies Preliminary Injunction In Ustekinumab Breach Of Contract Case
Article
03 Apr 2025
FDA Approves Fresenius's Denosumab Biosimilars
Article
26 Mar 2025
Celltrion Launches STEQEYMA® (ustekinumab-stba) In The United States
Article
25 Mar 2025
DC Circuit Holds That AI Cannot Be An Author Under Copyright Law
Article
24 Mar 2025
FDA Accepts BLA For Alvotech And Dr. Reddy's Denosumab Biosimilars
Article
11 Mar 2025
FDA Approves Celltrion's Denosumab Biosimilars
Article
19 Feb 2025
Regulatory Updates On Samsung's Denosumab Biosimilars
Article
19 Feb 2025
Dr. Reddy's Secures License From Henlius To Market Daratumumab Biosimilar In The U.S. And Europe
Article
13 Feb 2025
Regulatory And Commercial Updates On Bio-Thera's BAT2506 (Golimumab)
Article
06 Feb 2025
FDA Approves Celltrion's AVTOZMA (Tocilizumab-Anoh)
Article
04 Feb 2025
Teva Announces New Biosimilar Deals